Cite
HARVARD Citation
Martin-Blondel, G. et al. (2023). Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir. Clinical microbiology and infection. pp. 543.e5-543.e9. [Online].